Mergers & Acquisitions
February 11, 2025
Border
Less than
min read

Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6bn

Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6bn
Close Icon